Characterization of JNJ-80948543, a Novel CD79bxCD20xCD3 Trispecific T-Cell Redirecting Antibody for the Treatment of B-Cell Non-Hodgkin Lymphoma

被引：15

作者：

Kuchnio, Anna ^{[1
]}

Yang, Danlin ^{[2
]}

Vloemans, Nele ^{[1
]}

Lowenstein, Cassandra ^{[2
]}

Cornelissen, Ivo ^{[1
]}

Amorim, Ricardo ^{[1
]}

Han, Chao ^{[2
]}

Sukumaran, Siddharth ^{[2
]}

Janssen, Lut ^{[1
]}

Suls, Toon ^{[1
]}

Bekkers, Mariette ^{[1
]}

Lasorsa, Elena ^{[1
]}

Fontana, Lorena ^{[1
]}

Medeiros, Nicole ^{[2
]}

Wu, Bingyuan ^{[2
]}

Chen, Jun ^{[2
]}

Feldkamp, Michael ^{[2
]}

Wu, Sheng-Jiun ^{[2
]}

Habte, Habtom ^{[2
]}

Krayer, John ^{[2
]}

Holland, Cam ^{[2
]}

Deyoung, M. Phillip ^{[2
]}

Elsayed, Yusri A. ^{[2
]}

Philippar, Ulrike ^{[1
]}

机构：

[1] Janssen Res & Dev, Beerse, Belgium

[2] Janssen Res & Dev, Spring House, PA USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-168739

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3105 / 3106

页数：2

共 50 条

[31] Attenuation of CD8+ T-cell function by CD4+CD25+ regulatory T cells in B-cell non-Hodgkin's lymphoma
Yang, Zhi-Zhang
Novak, Anne J.
Ziesmer, Steven C.
Witzig, Thomas E.
Ansell, Stephen M.
CANCER RESEARCH, 2006, 66 (20) : 10145 - 10152
[32] Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma
Yuen, Sam
Phillips, Tycel J.
Bannerji, Rajat
Marlton, Paula
Gritti, Giuseppe
Seymour, John F.
Johnston, Anna
Arthur, Christopher
Dodero, Anna
Sharma, Sunil
Hirata, Jamie
Musick, Lisa
Flowers, Christopher R.
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1281 - 1289
[33] Clinical development of anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Makita, Shinichi
Yoshimura, Kiyoshi
Tobinai, Kensei
CANCER SCIENCE, 2017, 108 (06) : 1109 - 1118
[34] Chimeric Antigen Receptor T-Cell Therapy for Companion Canines with Spontaneous B-Cell Non-Hodgkin Lymphoma
O'Connor, Colleen M.
Olivares, Simon
Ang, Sonny
Champlin, Richard E.
Wilson-Robles, Heather M.
Cooper, Laurence J. N.
MOLECULAR THERAPY, 2013, 21 : S249 - S249
[35] Auto-tumor reactive cytotoxic T-Cell responses in B-Cell non-Hodgkin's lymphoma
Perambakam, S
Amin, K
Naresh, K
Advani, S
Nadkarni, J
LEUKEMIA & LYMPHOMA, 1997, 27 (1-2) : 145 - 152
[36] Novel bispecific antibodies in CD20-positive B-cell non-Hodgkin lymphomas
不详
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2021, 14 (SUPPL 6) : 137 - 138
[37] Radiobiology of radioimmunotherapy: Targeting CD20 B-cell antigen in non-Hodgkin's lymphoma
Hernandez, MC
Knox, SJ
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (05): : 1274 - 1287
[38] Identification of LAG3+T Cell Populations in the Tumor Microenvironment of Classical Hodgkin Lymphoma and B-Cell Non-Hodgkin Lymphoma
Takata, Katsuyoshi
Aoki, Tomohiro
Chong, Lauren C.
Milne, Katy
Miyata-Takata, Tomoko
Singh, Karanvir
Goodyear, Talia
Farinha, Pedro
Slack, Graham W.
Sehn, Laurie H.
Savage, Kerry J.
Nelson, Brad H.
Scott, David W.
Steidl, Christian
BLOOD, 2020, 136
[39] T-cell rich B-cell non-Hodgkin's lymphoma: A progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin's disease
deJong, D
vanGorp, J
SieGo, D
vanHeerde, P
HISTOPATHOLOGY, 1996, 29 (03) : 293 - 293
[40] T-cell rich B-cell non-Hodgkin's lymphoma: A progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin's disease
deJong, D
vanGorp, J
SieGo, D
VanHeerde, P
HISTOPATHOLOGY, 1996, 28 (01) : 15 - 24

← 1 2 3 4 5 →